Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Breast Cancer

Free Subscription Articles published in JAMA Retrieve available abstracts of 54 articles: HTML format Text format

Single Articles

September 2019
1. SLOMSKI A
   Adjuvant Therapy for HER2-Positive Breast Cancer.
   JAMA. 2019;322:1134.
   PubMed     Text format    
   
   
   
2. OWENS DK, Davidson KW, Krist AH, Barry MJ, et al
   Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement.
   JAMA. 2019;322:857-867.
   PubMed     Text format     Abstract available
   
   
   
3. NELSON HD, Fu R, Zakher B, Pappas M, et al
   Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
   JAMA. 2019;322:868-886.
   PubMed     Text format     Abstract available
   
   
   
4. JIN J
   Medications to Reduce Breast Cancer Risk.
   JAMA. 2019;322:900.
   PubMed     Text format    
   
   
   
5. PACE LE, Keating NL
   Medications to Reduce Breast Cancer Risk: Promise and Limitations.
   JAMA. 2019;322:821-823.
   PubMed     Text format    
   
   
   August 2019
6. IZZO MC, Bronner G, Shields CL
   Rapidly Progressive Vision Loss in a Patient With Breast Cancer.
   JAMA. 2019 Aug 22. pii: 2749078. doi: 10.1001/jama.2019.12691.
   PubMed     Text format    
   
   
   
7. OWENS DK, Davidson KW, Krist AH, Barry MJ, et al
   Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
   JAMA. 2019;322:652-665.
   PubMed     Text format     Abstract available
   
   
   
8. NELSON HD, Pappas M, Cantor A, Haney E, et al
   Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
   JAMA. 2019;322:666-685.
   PubMed     Text format     Abstract available
   
   
   
9. JIN J
   Should I Be Tested for BRCA Mutations?
   JAMA. 2019;322:702.
   PubMed     Text format    
   
   
   July 2019
10. SLOMSKI A
    Preventing Cardiotoxicity Associated With Breast Cancer Therapy.
    JAMA. 2019;322:296.
    PubMed     Text format    
    
    
    
11. 
    First PI3K Inhibitor for Breast Cancer.
    JAMA. 2019;322:19.
    PubMed     Text format    
    
    
    
12. CHOI JM
    An Unexpected Asset.
    JAMA. 2019;322:29.
    PubMed     Text format    
    
    
    June 2019
13. KEATING NL, Pace LE
    New Federal Requirements to Inform Patients About Breast Density: Will They Help Patients?
    JAMA. 2019;321:2275-2276.
    PubMed     Text format    
    
    
    May 2019
14. KERLIKOWSKE K, Miglioretti DL, Vachon CM
    Discussions of Dense Breasts, Breast Cancer Risk, and Screening Choices in 2019.
    JAMA. 2019 May 31. pii: 2735405. doi: 10.1001/jama.2019.6247.
    PubMed     Text format    
    
    
    
15. CRANDALL CJ, Livingston E
    Women's Health: A New JAMA Clinical Insights Series.
    JAMA. 2019;321:1676.
    PubMed     Text format    
    
    
    
16. POLITE BN, Gluck AR, Brawley OW
    Ensuring Equity and Justice in the Care and Outcomes of Patients With Cancer.
    JAMA. 2019;321:1663-1664.
    PubMed     Text format    
    
    
    April 2019
17. RUDDY KJ, Ganz PA
    Treatment of Nonmetastatic Breast Cancer.
    JAMA. 2019 Apr 12. pii: 2731086. doi: 10.1001/jama.2019.3927.
    PubMed     Text format    
    
    
    
18. VOELKER R
    Quick Uptakes: Taking the Uncertainty Out of Interpreting BRCA Variants.
    JAMA. 2019;321:1340-1341.
    PubMed     Text format    
    
    
    February 2019
19. SLOMSKI A
    BMI Not a Good Proxy for Breast Cancer Risk.
    JAMA. 2019;321:735.
    PubMed     Text format    
    
    
    January 2019
20. WAKS AG, Winer EP
    Breast Cancer Treatment: A Review.
    JAMA. 2019;321:288-300.
    PubMed     Text format     Abstract available
    
    
    
21. WAKS AG, Winer EP
    Breast Cancer Treatment.
    JAMA. 2019;321:316.
    PubMed     Text format    
    
    
    
22. DOMCHEK SM
    Risk-Reducing Mastectomy in BRCA1 and BRCA2 Mutation Carriers: A Complex Discussion.
    JAMA. 2019;321:27.
    PubMed     Text format    
    
    
    December 2018
23. SLOMSKI A
    Chemoimmunotherapy for Triple-Negative Breast Cancer.
    JAMA. 2018;320:2521.
    PubMed     Text format    
    
    
    
24. HERSHMAN DL, Unger JM, Crew K
    Acupuncture for Aromatase Inhibitor-Related Joint Pain Among Breast Cancer Patients.
    JAMA. 2018;320:2270-2271.
    PubMed     Text format    
    
    
    
25. LIU C, Zhang H, Sun C
    Acupuncture for Aromatase Inhibitor-Related Joint Pain Among Breast Cancer Patients.
    JAMA. 2018;320:2270.
    PubMed     Text format    
    
    
    
26. MAO JJ, Farrar JT
    Acupuncture for Aromatase Inhibitor-Related Joint Pain Among Breast Cancer Patients.
    JAMA. 2018;320:2269-2270.
    PubMed     Text format    
    
    
    August 2018
27. LEE GK, Sheckter CC
    Breast Reconstruction Following Breast Cancer Treatment-2018.
    JAMA. 2018 Aug 31. pii: 2701789. doi: 10.1001/jama.2018.12190.
    PubMed     Text format    
    
    
    
28. GROSS AL, Blot WJ, Visvanathan K
    BRCA1 and BRCA2 Testing in Medically Underserved Medicare Beneficiaries With Breast or Ovarian Cancer.
    JAMA. 2018;320:597-598.
    PubMed     Text format    
    
    
    
29. ABBASI J
    Can Acupuncture Keep Women on Their Breast Cancer Drugs?
    JAMA. 2018 Aug 8. pii: 2696922. doi: 10.1001/jama.2018.11068.
    PubMed     Text format    
    
    
    July 2018
30. SLOMSKI A
    Many Women With Early Breast Cancer May Not Need Chemotherapy.
    JAMA. 2018;320:332.
    PubMed     Text format    
    
    
    
31. HERSHMAN DL, Unger JM, Greenlee H, Capodice JL, et al
    Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial.
    JAMA. 2018;320:167-176.
    PubMed     Text format     Abstract available
    
    
    
32. ABBASI J
    Immunotherapy Leads to Complete Regression in Late-Stage Breast Cancer.
    JAMA. 2018;320:127.
    PubMed     Text format    
    
    
    June 2018
33. GILL J, Obley AJ, Prasad V
    Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing.
    JAMA. 2018;319:2377-2378.
    PubMed     Text format    
    
    
    
34. PLEVRITIS SK, Berry DA, Mandelblatt JS
    Contributions of Screening and Treatment to Mortality From Breast Cancer-Reply.
    JAMA. 2018;319:2336.
    PubMed     Text format    
    
    
    
35. CHEN HH
    Contributions of Screening and Treatment to Mortality From Breast Cancer.
    JAMA. 2018;319:2335-2336.
    PubMed     Text format    
    
    
    May 2018
36. KEATING NL, Pace LE
    Breast Cancer Screening in 2018: Time for Shared Decision Making.
    JAMA. 2018;319:1814-1815.
    PubMed     Text format    
    
    
    April 2018
37. BEJNORDI BE, Litjens G, van der Laak JA
    Machine Learning Compared With Pathologist Assessment-Reply.
    JAMA. 2018;319:1726.
    PubMed     Text format    
    
    
    
38. VAN SMEDEN M, Van Calster B, Groenwold RHH
    Machine Learning Compared With Pathologist Assessment.
    JAMA. 2018;319:1725-1726.
    PubMed     Text format    
    
    
    March 2018
39. KATZ SJ, Jagsi R, Morrow M
    Reducing Overtreatment of Cancer With Precision Medicine: Just What the Doctor Ordered.
    JAMA. 2018;319:1091-1092.
    PubMed     Text format    
    
    
    February 2018
40. PEACHMAN RR
    Weighing the Risks and Benefits of Hormonal Contraception.
    JAMA. 2018 Feb 28. pii: 2673941. doi: 10.1001/jama.2018.0448.
    PubMed     Text format    
    
    
    
41. HENNEMAN JR
    In Shadow and Light-Images of Transformation Through Breast Cancer.
    JAMA. 2018;319:532-534.
    PubMed     Text format    
    
    
    January 2018
42. BALLMAN KV, McCall LM, Giuliano AE
    Axillary vs Sentinel Lymph Node Dissection in Women With Invasive Breast Cancer-Reply.
    JAMA. 2018;319:306-307.
    PubMed     Text format    
    
    
    
43. UNO H, Hassett MJ, Wei LJ
    Axillary vs Sentinel Lymph Node Dissection in Women With Invasive Breast Cancer.
    JAMA. 2018;319:306.
    PubMed     Text format    
    
    
    
44. PLEVRITIS SK, Munoz D, Kurian AW, Stout NK, et al
    Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012.
    JAMA. 2018;319:154-164.
    PubMed     Text format     Abstract available
    
    
    
45. MANSON JE, Aragaki AK, Rossouw JE
    Menopausal Estrogen Therapy and Breast Cancer Mortality-Reply.
    JAMA. 2018;319:193-194.
    PubMed     Text format    
    
    
    
46. HICKEY M, McNamara HC, Mishra GD
    Menopausal Estrogen Therapy and Breast Cancer Mortality.
    JAMA. 2018;319:193.
    PubMed     Text format    
    
    
    December 2017
47. EHTESHAMI BEJNORDI B, Veta M, Johannes van Diest P, van Ginneken B, et al
    Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer.
    JAMA. 2017;318:2199-2210.
    PubMed     Text format     Abstract available
    
    
    
48. GOLDEN JA
    Deep Learning Algorithms for Detection of Lymph Node Metastases From Breast Cancer: Helping Artificial Intelligence Be Seen.
    JAMA. 2017;318:2184-2186.
    PubMed     Text format    
    
    
    November 2017
49. ENGELHARDT KE, Barnard C, Bilimoria KY
    Wrong-Site Surgery.
    JAMA. 2017;318:2033-2034.
    PubMed     Text format    
    
    
    
50. THOMAS R, Fysh ETH, Smith NA, Lee P, et al
    Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial.
    JAMA. 2017;318:1903-1912.
    PubMed     Text format     Abstract available
    
    
    September 2017
51. SLOMSKI A
    Low-Fat Diet Reduces Mortality After Breast Cancer.
    JAMA. 2017;318:1099.
    PubMed     Text format    
    
    
    
52. GIULIANO AE, Ballman KV, McCall L, Beitsch PD, et al
    Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
    JAMA. 2017;318:918-926.
    PubMed     Text format     Abstract available
    
    
    
53. LIVINGSTON EH, Li HC
    Breast Cancer Surgery: Less Is More.
    JAMA. 2017;318:909-911.
    PubMed     Text format    
    
    
    
54. MCNEIL M
    Menopausal Hormone Therapy: Understanding Long-term Risks and Benefits.
    JAMA. 2017;318:911-913.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: